FutureChem Co.Ltd (220100) - Total Assets
Based on the latest financial reports, FutureChem Co.Ltd (220100) holds total assets worth ₩70.28 Billion KRW (≈ $47.63 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See FutureChem Co.Ltd shareholders equity for net asset value and shareholders' equity analysis.
FutureChem Co.Ltd - Total Assets Trend (2016–2024)
This chart illustrates how FutureChem Co.Ltd's total assets have evolved over time, based on quarterly financial data.
FutureChem Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
FutureChem Co.Ltd's total assets of ₩70.28 Billion consist of 53.1% current assets and 46.9% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩-10.42 Million | 8.0% |
| Accounts Receivable | ₩3.46 Billion | 4.7% |
| Inventory | ₩1.31 Billion | 1.8% |
| Property, Plant & Equipment | ₩25.72 Billion | 34.6% |
| Intangible Assets | ₩5.67 Billion | 7.6% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how FutureChem Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see FutureChem Co.Ltd market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: FutureChem Co.Ltd's current assets represent 53.1% of total assets in 2024, a decrease from 75.4% in 2016.
- Cash Position: Cash and equivalents constituted 8.0% of total assets in 2024, down from 52.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 3.0% in 2016.
- Asset Diversification: The largest asset category is property, plant & equipment at 34.6% of total assets.
FutureChem Co.Ltd Competitors by Total Assets
Key competitors of FutureChem Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.34 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥15.32 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
FutureChem Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.47 | 12.43 | 2.46 |
| Quick Ratio | 2.38 | 12.01 | 2.41 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩21.89 Billion | ₩38.15 Billion | ₩30.43 Billion |
FutureChem Co.Ltd - Advanced Valuation Insights
This section examines the relationship between FutureChem Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.06 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 2.2% |
| Total Assets | ₩74.42 Billion |
| Market Capitalization | $274.64 Million USD |
Valuation Analysis
Below Book Valuation: The market values FutureChem Co.Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: FutureChem Co.Ltd's assets grew by 2.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for FutureChem Co.Ltd (2016–2024)
The table below shows the annual total assets of FutureChem Co.Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩74.42 Billion ≈ $50.43 Million |
+2.18% |
| 2023-12-31 | ₩72.83 Billion ≈ $49.36 Million |
-17.90% |
| 2022-12-31 | ₩88.72 Billion ≈ $60.12 Million |
+15.01% |
| 2021-12-31 | ₩77.14 Billion ≈ $52.27 Million |
-6.45% |
| 2020-12-31 | ₩82.46 Billion ≈ $55.88 Million |
+30.44% |
| 2019-12-31 | ₩63.21 Billion ≈ $42.84 Million |
-1.30% |
| 2018-12-31 | ₩64.05 Billion ≈ $43.40 Million |
+77.91% |
| 2017-12-31 | ₩36.00 Billion ≈ $24.40 Million |
+8.73% |
| 2016-12-31 | ₩33.11 Billion ≈ $22.44 Million |
-- |
About FutureChem Co.Ltd
FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis. Its products i… Read more